<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[zocor Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/zocor.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to zocor]]></description>
	<s:counts start="0" returned="20" found="24" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Schering-Plough Now in the Feds' Crosshairs]]></title>
		<link><![CDATA[http://www.bnet.com/5208-14054-0.html?forumID=1&threadID=2699&messageID=13002&start=0]]></link>
		<description><![CDATA[Schering-Plough Now in the Feds' CrosshairsThe Great Disappointment of EthicsPublished on www.brainblogger.com:A Failed Attempt to Improve Misperceived Greatness:  The ENHANCE TrialWhile it seems that pharmaceutical company sponsors of clinical trials usually end up with results that clearly favor their meds studied in their trial, there are rare exceptions, and...]]></description>
		<s:doctype><![CDATA[Discussion threads]]></s:doctype>
		<pubDate>Thu, 10 Jul 2008 17:19:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/enhance+trial.html"><![CDATA[ENHANCE Trial]]></category>
		<category domain="http://resources.bnet.com/topic/schering.html"><![CDATA[Schering]]></category>
		<category domain="http://resources.bnet.com/topic/schering-plough+corp..html"><![CDATA[Schering-Plough Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/trial+result.html"><![CDATA[trial result]]></category>
		<category domain="http://resources.bnet.com/topic/vytorin.html"><![CDATA[Vytorin]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
		<category domain="tickers">MRK,SGP</category>
	</item>
	<item>
		<title><![CDATA[Is Merck Hanging Schering Out to Dry on Vytorin?]]></title>
		<link><![CDATA[http://www.bnet.com/5208-14054-0.html?forumID=1&threadID=2684&messageID=12779&start=0]]></link>
		<description><![CDATA[Is Merck Hanging Schering Out to Dry on Vytorin?VytorinPublished on www.brainblogger.com:A Failed Attempt to Improve Misperceived Greatness:  The ENHANCE TrialWhile it seems that pharmaceutical company sponsors of clinical trials usually end up with results that clearly favor their meds studied in their trial, there are rare exceptions, and Merck...]]></description>
		<s:doctype><![CDATA[Discussion threads]]></s:doctype>
		<pubDate>Mon, 07 Jul 2008 14:41:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/enhance+trial.html"><![CDATA[ENHANCE Trial]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/schering.html"><![CDATA[Schering]]></category>
		<category domain="http://resources.bnet.com/topic/vytorin.html"><![CDATA[Vytorin]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[How Pharma Stacks the Deck with Medical Journals]]></title>
		<link><![CDATA[http://www.bnet.com/5208-14054-0.html?forumID=1&threadID=2548&messageID=12068&start=0]]></link>
		<description><![CDATA[How Pharma Stacks the Deck with Medical JournalsStatistical GymnasticsPublished on www.brainblogger.com:A Failed Attempt to Improve Misperceived Greatness:  The ENHANCE TrialWhile it seems that pharmaceutical company sponsors of clinical trials usually end up with results that clearly favor their meds studied in their trial, there are rare exceptions, and Merck...]]></description>
		<s:doctype><![CDATA[Discussion threads]]></s:doctype>
		<pubDate>Wed, 18 Jun 2008 21:31:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/enhance+trial.html"><![CDATA[ENHANCE Trial]]></category>
		<category domain="http://resources.bnet.com/topic/schering.html"><![CDATA[Schering]]></category>
		<category domain="http://resources.bnet.com/topic/trial+result.html"><![CDATA[trial result]]></category>
		<category domain="http://resources.bnet.com/topic/vytorin.html"><![CDATA[Vytorin]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
	</item>
	<item>
		<title><![CDATA[Prescriptions for Cholesterol Drugs Rise with New Generics]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200702/ai_n21888861]]></link>
		<description><![CDATA[To: HEALTH/MEDICAL EDITORSContact: Susan Herold of Consumers Union, +1-202-462-6262, sherold@consumer.org WASHINGTON, Feb. 13 /PRNewswire-USNewswire/ -- Prescriptions for the cholesterol-lowering medicines known as statins rose by an average of 500,000 a month between October 2005 and December 2006, according to a new analysis by Consumers Union and Consumer Reports Best Buy...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 13 Feb 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cholesterol.html"><![CDATA[cholesterol]]></category>
		<category domain="http://resources.bnet.com/topic/consumer+reports.html"><![CDATA[Consumer Reports]]></category>
		<category domain="http://resources.bnet.com/topic/consumers+union.html"><![CDATA[Consumers Union]]></category>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/prescription.html"><![CDATA[prescription]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Cheaper Zocor throws generic market a curveball]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_km2921/is_200610/ai_n16914636]]></link>
		<description><![CDATA[A recent change in policy adopted by large pharmaceutical firm Merck to offer greater discounts for its cholesterol-lowering drug Zocor has given employer-clients, pharmacy benefit managers and insurers a tough benefit design decision: Should they stick w A recent change in policy adopted by large pharmaceutical firm Merck to offer...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 01 Oct 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/insurance+company.html"><![CDATA[insurance company]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pbm.html"><![CDATA[PBM]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Cheaper Zocor throws generic market a curveball]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_km2922/is_200609/ai_n16914478]]></link>
		<description><![CDATA[A recent policy change by Merck to offer greater discounts for its cholesterol-lowering drug Zocor has employers, pharmacy benefit managers and insurers faced with making a tough decision: Should they follow what has been general tradition to this point a A recent policy change by Merck to offer greater discounts...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 15 Sep 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/insurance+company.html"><![CDATA[insurance company]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pbm.html"><![CDATA[PBM]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Expiring drug patents provide opening to promote generics; Cost savings may be major.(News)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5252/is_200607/ai_n20161478]]></link>
		<description><![CDATA[Byline: GLORIA GONZALEZ    The recent expiration of the patents on blockbuster prescription  drugs Zocor and Zoloft represents a tremendous opportunity to  reinvigorate generic drug promotion programs, insurers and pharmacy  benefit managers say.    The  Byline: GLORIA GONZALEZ    The...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 17 Jul 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blue+cross+blue+shield.html"><![CDATA[Blue Cross Blue Shield]]></category>
		<category domain="http://resources.bnet.com/topic/brand.html"><![CDATA[brand]]></category>
		<category domain="http://resources.bnet.com/topic/cost+savings.html"><![CDATA[cost savings]]></category>
		<category domain="http://resources.bnet.com/topic/expiration.html"><![CDATA[expiration]]></category>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/insurance+company.html"><![CDATA[insurance company]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Lipitor faces first big generic hurdle]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmusa/is_200607/ai_n16550346]]></link>
		<description><![CDATA[As employers look to cut prescription drug costs, some consumers are finding Lipitor, the world's most popular drug, harder and more expensive to get.  The leading anti-cholesterol drug is under pressure as employers push for use of lower-cost generics. In June, No. 2 anti-cholesterol drug Zocor went generic, setting...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 10 Jul 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/consumers+union.html"><![CDATA[Consumers Union]]></category>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/prescription.html"><![CDATA[prescription]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Zocor move muddles generics strategies.(usage of generic drugs)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5252/is_200607/ai_n20165297]]></link>
		<description><![CDATA[Byline: GLORIA GONZALEZ    Pharmaceutical manufacturer Merck & Co.'s decision to  offer pricing incentives to encourage insurers and pharmacy benefit  managers to favor its brand-name drug Zocor over recently introduced  generic versions has initiat  Byline: GLORIA GONZALEZ    Pharmaceutical manufacturer Merck &...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 10 Jul 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pricing+strategy.html"><![CDATA[pricing strategy]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[strategy]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic ZocorŪ]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_June_23/ai_n26905658]]></link>
		<description><![CDATA[JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that Novartis' generic unit, Sandoz, Inc., has filed a complaint in the United States District Court for the District of Columbia, seeking approval of its generic ZocorR products in the face of an April 30, 2006 decision of the same...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 23 Jun 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/sandoz.html"><![CDATA[Sandoz]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Aetna Pharmacy Management to Launch a Generic First Program in Response to Zocor's Patent Expiring]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_June_22/ai_n26904713]]></link>
		<description><![CDATA[HARTFORD, Conn. -- Aetna (NYSE:AET) Pharmacy Management APM today announced it will encourage members to use generics first when the patent for Zocor expires this Friday. Aetna is supporting Teva Pharmaceuticals (NASDAQ:TEVA), which manufactures the generic alternative Simvastatin, to help provide customers with continued access to affordable, appropriate prescription drug...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 22 Jun 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aetna+inc..html"><![CDATA[Aetna Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[Generic]]></category>
		<category domain="http://resources.bnet.com/topic/pharmacy.html"><![CDATA[Pharmacy]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AET</category>
		<category domain="tickers">AET</category>
	</item>
	<item>
		<title><![CDATA[Enhancing employee health]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_km2922/is_200606/ai_n16914348]]></link>
		<description><![CDATA[What's for lunch today? Pizza and potato chips? Fish and salad? We love choices at mealtime, but many of us make poor ones by eating too many fatty foods. That's why millions of Americans have high cholesterol, a major risk factor for heart disease and st What's for lunch today?...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Jun 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/food.html"><![CDATA[food]]></category>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/zetia.html"><![CDATA[Zetia]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[PFIZER INC - Research Update.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5937/is_200605/ai_n23960751]]></link>
		<description><![CDATA[Pfizer's Lipitor Provides Greater Reductions in Heart Attack,         Stroke and Cardiovascular Procedures at an Overall Cost Savings                      Compared to Zocor, New...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 16 May 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ideal.html"><![CDATA[IDEAL]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Ranbaxy gets taste of Merck bestseller.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5936/is_200605/ai_n23948471]]></link>
		<description><![CDATA[May 3--NEW DELHI -- Ranbaxy and Israeli generic major Teva  Pharmaceutical are likely to get a windfall by having six months without  competition to sell their generic versions of Merck's blockbuster  cholesterol drug Zocor.    May 3--NEW DELHI -- Ranbaxy and Israeli generic major Teva...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 03 May 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/ranbaxy.html"><![CDATA[Ranbaxy]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[ZOCOR]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[New Analysis Finds Medicare, Taxpayers Could Save $8.2B a Year if Seniors Were Prescribed Generics for Cholesterol Reduction]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200601/ai_n21865589]]></link>
		<description><![CDATA[WASHINGTON, Jan. 11 /U.S. Newswire/ -- Potential savings of $8.2 billion could be achieved in 2007 if Medicare beneficiaries were prescribed effective, lower-cost generic statins to reduce cholesterol instead of higher-priced brands, according to a new analysis by Consumers Union and Consumer Reports Best Buy Drugs.  The savings would...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 11 Jan 2006 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[analysis]]></category>
		<category domain="http://resources.bnet.com/topic/beneficiary.html"><![CDATA[beneficiary]]></category>
		<category domain="http://resources.bnet.com/topic/best+buy+co.+inc..html"><![CDATA[Best Buy Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cholesterol.html"><![CDATA[cholesterol]]></category>
		<category domain="http://resources.bnet.com/topic/consumer+reports.html"><![CDATA[Consumer Reports]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/lipitor.html"><![CDATA[Lipitor]]></category>
		<category domain="http://resources.bnet.com/topic/medicare.html"><![CDATA[Medicare]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BBY</category>
		<category domain="tickers">BBY</category>
	</item>
	<item>
		<title><![CDATA[PFIZER INC - Research Update.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5937/is_200511/ai_n23958773]]></link>
		<description><![CDATA[New Lipitor Study Demonstrates That Intensive LDL Cholesterol Lowering in       Heart Disease Patients Can Reduce Cardiovascular Events, Pfizer Says        DALLAS, Nov. 15 -- Patients who had a previous heart attack and took  Pfizer Inc's cholesterol- ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 15 Nov 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[ZOCOR]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Forbes Medi-Tech Preclinical Study Results Demonstrate Cholesterol-Lowering Effects of FM-VP4/Statin 'Zocor' Combination and Effects on Obesity]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Sept_15/ai_n15391762]]></link>
		<description><![CDATA[VANCOUVER, British Columbia -- Forbes Medi-Tech Inc. (NASDAQ:FMTI)(TSX:FMI) today  announced the results from two pre-clinical studies involving the  Company's cholesterol-lowering drug, FM-VP4. The first study was  designed to assess the effects of Forbes' cholesterol-lowering drug  candidate, FM-VP4, in combination with Simvastatin ZocorRi from  Merck (NYSE:MRK),...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 15 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/forbes.html"><![CDATA[Forbes]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Merck & Co. Inc. (Active Pharmaceutical Ingredient Watch).(to change label for Zocor)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200304/ai_n13360598]]></link>
		<description><![CDATA[MERCK & Co. Inc. has received FDA approval for changes to the  label for its cholesterol-lowering drug Zocor ...    MERCK & Co. Inc. has received FDA approval for changes to the  label for its cholesterol-lowering drug Zocor simvastatin to recommend  a 40mg starting dose...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 28 Apr 2003 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[Merck & Co. Inc. (Active Pharmaceutical Ingredient Watch).(alters Zocor label)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200206/ai_n13210905]]></link>
		<description><![CDATA[MERCK & Co. Inc. reports that changes to the existing label for  cholesterol-lowering drug Zocor simvastatin further clarify the risk  of myopathy and rhabdomyolysis, particularly with higher doses and when  used with certain drugs. Merck reques    MERCK & Co. Inc. reports that changes to...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 17 Jun 2002 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[DTC Marketing.(direct-to-consumer marketing by pharmaceutical manufacturers)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6398/is_200004/ai_n25592641]]></link>
		<description><![CDATA[Direct-to-consumer drug advertising has entered its next  evolutionary phase. The banal images of smiley, happy people in  physician-targeted advertising later translated into consumer ads are  out. Star power is in. Pharmaceutical companies are now tur  Direct-to-consumer drug advertising has entered its next  evolutionary phase. The...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 03 Apr 2000 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/celebrity.html"><![CDATA[celebrity]]></category>
		<category domain="http://resources.bnet.com/topic/dtc+advertising.html"><![CDATA[DTC Advertising]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/zocor.html"><![CDATA[Zocor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
</channel>
</rss>
